Filter Results :

Your search for Lymphoma returned 102 reports

Sort by


Non-Hodgkin Lymphoma - Pipeline Review, H2 2017

28 Nov 2017  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Hodgkin Lymphoma - Pipeline Review, H2 2017, provides an overview of the Non-Hodgkin Lymphoma (Oncology) pipeline landscape.Non-Hodgkin lymphoma (also known as non-Hodgkin’s lymphoma, NHL, or sometimes jus...

$ 2,500.00

Read More

Tissue Diagnostics Market by Product (Consumables, Instruments), Technology (Immunohistochemistry, in Situ Hybridization, Digital Pathology & Workflow), Disease (Breast Cancer, Gastric Cancer, Lymphoma), End User (Hospital, CRO) - Global Forecast to 2022

09 Nov 2017  |  Published by:  MarketsandMarkets
Global tissue diagnostics market projected to grow at a CAGR of 6.9% during the forecast periodThe tissue diagnostics market is expected to reach USD 5.14 billion by 2022 from USD 3.68 billion in 2017, at a CAGR of 6.9%. Factors driving the growth of this market include the rising incidence of cance...

$ 5,650.00

Read More

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Insights, 2017

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s, “Peripheral T-Cell Lymphoma (PTCL)-Pipeline Insights, 2017”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Peripheral T-Cell Lymphoma (PTCL...

$ 1,250.00
$ 1,000.00
( Save 20% )

Read More

B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2017

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s, “B-Cell Non-Hodgkin Lymphoma -Pipeline Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across B-Cell Non-Hodgkin Lymphoma . The report provides a complete understanding of the pipeline activities covering all clinical, pre-c...

$ 1,500.00
$ 1,200.00
( Save 20% )

Read More

B-Cell Lymphomas - Pipeline Insight, 2017

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s, “B-Cell Lymphomas -Pipeline Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across B-Cell Lymphomas . The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery ...

$ 2,000.00
$ 1,600.00
( Save 20% )

Read More

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Insight, 2017

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s, “Anaplastic Large Cell Lymphoma (ALCL) -Pipeline Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across Anaplastic Large Cell Lymphoma (ALCL) . The report provides a complete understanding of the pipeline activities covering...

$ 1,250.00
$ 1,000.00
( Save 20% )

Read More

Indolent Lymphoma - Epidemiology Insights to 2025

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s “Indolent Lymphoma -Epidemiology Forecast, 2025” provides an overview of the epidemiology trends of Indolent Lymphoma in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Indolent Lymphoma. The Re...

$ 2,950.00
$ 2,360.00
( Save 20% )

Read More

Indolent Lymphoma - Market Insights, Epidemiology and Market Forecast -2025

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s “Indolent Lymphoma - Market Insights, Epidemiology and Market Forecast – 2025” report provides an overview of the disease and in depth research related to Indolent Lymphoma for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025...

$ 5,750.00
$ 4,600.00
( Save 20% )

Read More

Indolent Lymphoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s, Indolent Lymphoma - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017” report provides comprehensive insights about marketed and Phase III products for the Indolent Lymphoma. The report includes information of marketed products including their product description...

$ 2,000.00
$ 1,600.00
( Save 20% )

Read More

B-Cell Lymphomas - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s, B-Cell Lymphomas - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017” report provides comprehensive insights about marketed and Phase III products for the B-Cell Lymphomas. The report includes information of marketed products including their product description, ...

$ 2,250.00
$ 1,800.00
( Save 20% )

Read More

Peripheral T-Cell Lymphoma (PTCL) - Market Insights, Epidemiology and Market Forecast-2025

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s “Peripheral T-Cell Lymphoma (PTCL) - Market Insights, Epidemiology and Market Forecast – 2025” Reports provides an overview of the disease and global market size of the Peripheral T-Cell Lymphoma (PTCL) for the 7MM (United States, Germany, France, Italy, Spain and UK). The Report cove...

$ 5,750.00
$ 4,600.00
( Save 20% )

Read More

Cutaneous T-Cell Lymphoma(CTCL) - Market Insights, Epidemiology and Market Forecast-2025

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s “Cutaneous T-Cell Lymphoma(CTCL) - Market Insights, Epidemiology and Market Forecast – 2025” Reports provides an overview of the disease and global market size of the Cutaneous T-Cell Lymphoma(CTCL) for the 7MM (United States, Germany, France, Italy, Spain and UK). The Report covers t...

$ 5,750.00
$ 4,600.00
( Save 20% )

Read More

B-Cell Lymphomas - Market Insights, Epidemiology and Market Forecast-2025

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight’s “B-Cell Lymphomas - Market Insights, Epidemiology and Market Forecast – 2025” Reports provides an overview of the disease and global market size of the B-Cell Lymphomas for the 7MM (United States, Germany, France, Italy, Spain and UK). The Report covers the therapeutics market revenue...

$ 5,750.00
$ 4,600.00
( Save 20% )

Read More

Peripheral T-Cell Lymphoma (PTCL)- Epidemiology Insights to 2025

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight “ Peripheral T-Cell Lymphoma (PTCL) - Epidemiology Forecast To 2025” provides an overview of the epidemiology trends of Peripheral T-Cell Lymphoma (PTCL) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted...

$ 2,950.00
$ 2,360.00
( Save 20% )

Read More

Cutaneous T-Cell Lymphoma(CTCL)- Epidemiology Insights to 2025

01 Nov 2017  |  Published by:  DelveInsight
DelveInsight “ Cutaneous T-Cell Lymphoma(CTCL) - Epidemiology Forecast To 2025” provides an overview of the epidemiology trends of Cutaneous T-Cell Lymphoma(CTCL) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted dat...

$ 2,950.00
$ 2,360.00
( Save 20% )

Read More
Total 102 records.